💊 Mepivacaine (Polocaine-mpf, Polocaine)
Mepivacaine is an injectable local anesthetic used to produce local or regional anesthesia and analgesia. It is given by local infiltration, peripheral nerve block, or central neural techniques such as epidural and caudal blocks. It should be administered only by clinicians able to manage toxic reactions and emergencies.
In Arabic: ميبيفاكايين (هيدروكلوريد الميبيفاكايين)✅ What it is used for
- Local or regional analgesia and anesthesia by local infiltration
- Peripheral nerve blocks
- Central neural techniques, including epidural and caudal blocks
🧪 Active ingredient
The active ingredient is mepivacaine hydrochloride, an amide-type local anesthetic that blocks the generation and conduction of nerve impulses, producing progressive loss of pain, temperature, touch, proprioception, and skeletal muscle tone.
🌿 Benefits
- Effective local or regional anesthesia of the target area
- Can be used by several routes (infiltration, nerve block, epidural, caudal)
- Tolerated by pediatric patients as well as adults when dosing is carefully measured
📝 How to use
- This medicine is given by injection by a qualified clinician only; it is not self-administered
- The dose and concentration are set by the doctor or pharmacist according to the procedure, the area to be anesthetized, and the patient's age and condition
- The smallest dose and concentration that achieve the desired effect are used
- Dose is reduced for elderly and debilitated patients and those with cardiac and/or liver disease
- Rapid injection of a large volume should be avoided and fractional doses used when feasible
💊 Dosage forms
- Injection solution 1%, 1.5% and 2% (single-dose vials without preservatives)
- Multiple-dose vials (1% and 2%) containing a preservative (methylparaben)
- Not intended for spinal anesthesia or dental use
⚠️ Common side effects
- Restlessness or anxiety
- Dizziness
- Ringing in the ears (tinnitus) and blurred vision
- Tremors
- Nausea, vomiting, chills, and constriction of the pupils
- Drowsiness
🚨 Serious — seek medical help
- Convulsions, unconsciousness and respiratory arrest when blood levels become too high
- Cardiovascular effects: slow heart rate, heart block, low or sometimes high blood pressure, ventricular arrhythmias, possibly cardiac arrest
- Total or high spinal block after unintentional subarachnoid injection: underventilation or apnea and low blood pressure
- Methemoglobinemia: bluish skin discoloration or abnormal blood color, possibly delayed by some hours
- Rare allergic-type reactions: hives, itching, angioneurotic edema (including laryngeal edema), dizziness, fainting, and possibly severe hypotension
⛔ Do not use if
- Known hypersensitivity to mepivacaine, to any amide-type local anesthetic, or to other components of the solution
❗ Warnings & precautions
- Must be used only by clinicians well versed in managing dose-related toxicity and emergencies, with oxygen and resuscitation equipment immediately available
- Delay in managing toxicity or underventilation may lead to acidosis, cardiac arrest, and possibly death
- Higher risk of methemoglobinemia in patients with G6PD deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, infants under 6 months, and those exposed to oxidizing agents
- Solutions with preservatives (multiple-dose vials) should not be used for epidural or caudal anesthesia
- Not approved for intra-articular infusion; chondrolysis has been reported after such use of local anesthetics
- Risk of toxic reactions may be greater with impaired kidney function, especially in elderly patients
- Total dose in any 24-hour period should not exceed 1,000 mg
- Discard unused portions of single-dose vials; do not use discolored solutions or those with particulate matter
🔄 Drug interactions
- MAO inhibitors and tricyclic antidepressants: with epinephrine- or norepinephrine-containing local anesthetic solutions, severe prolonged hypertension may occur; concurrent use should generally be avoided
- Vasopressor drugs and ergot-type oxytocic drugs: may cause severe, persistent hypertension or cerebrovascular accidents
- Phenothiazines and butyrophenones: may reduce or reverse the pressor effect of epinephrine
- Drugs associated with methemoglobinemia: nitrates/nitrites (e.g., nitroglycerin, nitrous oxide), other local anesthetics, some antineoplastics (e.g., cyclophosphamide, hydroxyurea), antibiotics (dapsone, nitrofurantoin, sulfonamides), antimalarials (chloroquine, primaquine), anticonvulsants (phenobarbital, phenytoin, sodium valproate), and others such as acetaminophen, metoclopramide, quinine, sulfasalazine
- Tell your doctor about all medicines you take
🤰 Pregnancy
Animal reproduction studies have not been conducted and there are no adequate, well-controlled studies in pregnant women. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It has been used for obstetrical analgesia by epidural, caudal, and paracervical routes without evidence of adverse fetal effects when maximum safe dosages and strict technique are followed.
🍼 Breastfeeding
It is not known whether local anesthetics are excreted in human milk. Because many drugs are, caution should be exercised when given to a nursing woman; consult your doctor.
🧒 Children
Pediatric patients tolerate the local anesthetic as well as adults, but the dose must be carefully measured as a percentage of the adult dose based on weight and should not exceed 5 to 6 mg/kg (2.5 to 3 mg/lb), especially in those under 30 lbs. In children under 3 years or under 30 lbs, concentrations below 2% (e.g., 0.5% to 1.5%) should be used. Infants under 6 months are more susceptible to methemoglobinemia.
👴 Older adults
Elderly patients require a reduced dose; one study showed a 40% decrease in mepivacaine needed to block a given number of dermatomes in patients aged 60 to 79 years versus young adults. Mepivacaine and its metabolites are substantially excreted by the kidney, so toxic risk may be greater with impaired renal function and monitoring of renal function may be useful.
🌡️ Storage
Store at 20° to 25°C (68° to 77°F); brief exposure up to 40°C (104°F) does not adversely affect the product. Discard unused portions of single-dose vials. Do not use solutions that are discolored or contain particulate matter.
⏰ Missed dose
Not applicable, as the medicine is given once by the clinician during the procedure rather than on a dosing schedule followed by the patient.
🆘 Overdose
Toxicity is usually related to high plasma levels from overdose, unintentional intravascular injection, or unintended subarachnoid injection, and affects the central nervous and cardiovascular systems (convulsions, loss of consciousness, respiratory arrest, hypotension, arrhythmias). Management by the clinical team includes continuous monitoring, establishing a patent airway, ventilation with 100% oxygen, controlling convulsions, and supporting circulation. This is a medical emergency.
💰 Price & brands in your area
Local prices are currently available for Palestine; more countries are coming. Ask your pharmacist for local price and alternatives.
📍 Find the nearest pharmacy
Your location is used only in your browser to show nearby pharmacies — we don't store it.
Open in Google Maps👨⚕️ For healthcare professionals
Mechanism of action
An amide-type local anesthetic that blocks generation and conduction of nerve impulses, presumably by raising the threshold for electrical excitation, slowing impulse propagation, and reducing the rate of rise of the action potential. Loss of function proceeds in order: pain, temperature, touch, proprioception, skeletal muscle tone. Systemic absorption affects the cardiovascular and central nervous systems (stimulation, then depression).
Labeled dosing
Dose varies with the procedure, area, tissue vascularity, number of neuronal segments, depth and duration of anesthesia required, individual tolerance, and physical condition. The recommended single adult dose (or total of a series in one procedure) for unsedated, healthy, normal-sized individuals should not usually exceed 400 mg; doses up to 7 mg/kg (550 mg) have been given without adverse effect but are not recommended except in exceptional circumstances, and should not be repeated at intervals under 1.5 hours. Total dose in any 24 hours should not exceed 1,000 mg. Indicated concentrations: local infiltration 0.5% (via dilution) or 1%; peripheral nerve blocks 1% and 2%; epidural and caudal blocks 1%, 1.5%, 2%. Pediatric dose should not exceed 5 to 6 mg/kg, using concentrations below 2% for children under 3 years or under 30 lbs. Reduce doses in elderly, debilitated, and cardiac and/or liver disease patients.
- Requires immediate availability of oxygen, resuscitative drugs and equipment, and personnel before use
- Methemoglobinemia: discontinue the drug and any oxidizing agents; supportive care (oxygen, hydration); severe cases may need methylene blue, exchange transfusion, or hyperbaric oxygen
- For toxicity: ventilate with 100% oxygen; if needed, succinylcholine 50 to 100 mg IV, or diazepam 5 to 10 mg or thiopental 50 to 100 mg IV to facilitate ventilation and control convulsions; support circulation with fluids and vasopressors as indicated
- Preservative-containing (multiple-dose) products are not for epidural or caudal use
- Not approved for intra-articular infusion (chondrolysis) and not intended for spinal anesthesia or dental use
- Unintentional subarachnoid injection may cause total/high spinal block with hypotension and respiratory paralysis
🎓 Key points for students
- Mepivacaine is an amide-type local anesthetic (amide linkage between aromatic nucleus and amino group) that is very resistant to acid and alkaline hydrolysis
- Mechanism: blocks nerve impulse generation and conduction by raising excitation threshold, slowing propagation, and reducing rate of rise of the action potential
- Order of lost function: pain, temperature, touch, proprioception, skeletal muscle tone
- Systemic toxicity is dose-related and involves the CNS (excitation then depression) and the heart (depressed conduction and contractility)
- Factors affecting plasma protein binding (acidosis, systemic disease, competing drugs) may reduce tolerance
- Cross sensitivity among amide-type local anesthetics has been reported
- Associated with methemoglobinemia, especially with other oxidizing drugs
EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.
Try EME free How we protect your data❓ FAQ
What is mepivacaine used for?
It is an injectable local anesthetic used to numb a specific area by local infiltration, nerve blocks, or epidural and caudal blocks.
Can I use it myself?
No. It is given only by a qualified clinician in a setting equipped to manage emergencies, and the doctor determines the dose and concentration for your situation.
What are the common side effects?
Restlessness, dizziness, ringing in the ears, blurred vision, tremors, nausea, vomiting and drowsiness may occur; severe reactions such as convulsions or heart rhythm problems can happen at high blood levels, which is why patients are closely monitored.
Is it safe in pregnancy or breastfeeding?
In pregnancy it should be used only if the potential benefit justifies the risk to the fetus; it has been used in labor without evidence of fetal harm when safe doses and proper technique are followed. It is not known whether it passes into breast milk, so caution is advised.
Who should not receive it?
People with known hypersensitivity to mepivacaine, other amide-type local anesthetics, or components of the solution. Tell your doctor if you have G6PD deficiency, heart, lung, liver or kidney problems.
Does it interact with other medicines?
Yes, for example MAO inhibitors and tricyclic antidepressants with epinephrine-containing solutions, and drugs that increase methemoglobinemia risk such as nitrates and some antibiotics. Tell your doctor about everything you take.
⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2022-10), simplified. Updated: 2026-11-15.